Passage BIO, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Passage BIO, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q3 2024.
  • Passage BIO, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $14M, a 17.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $14M -$3.01M -17.6% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $16.8M -$2.59M -13.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $17.1M -$2.5M -12.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $16.9M -$2.87M -14.5% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $17M -$2.85M -14.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $19.4M -$640K -3.19% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $19.6M -$622K -3.08% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $19.7M Dec 31, 2022 10-K 2024-03-04
Q3 2022 $19.9M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $20.1M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $20.2M Mar 31, 2022 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.